Response to Luz & Mash on cardiac toxicity of ibogaine
Addiction
.
2022 Mar;117(3):837-838.
doi: 10.1111/add.15775.
Epub 2021 Dec 13.
Authors
Arnt Schellekens
1
,
Kees Kramers
2
,
Thomas Knuijver
1
,
Maarten Belgers
3
,
Rogier Donders
4
,
Robbert-Jan Verkes
5
Affiliations
1
Radboud University Nijmegen, Nijmegen, HE, the Netherlands.
2
Radboudumc Afdeling Farmacologie en toxicologie, Nijmegen, Gelderland, the Netherlands.
3
IrisZorg, Arnhem, Gelderland, the Netherlands.
4
Radboud Institute for Health Sciences, Radboud University Nijmegen Medical Center, the Netherlands.
5
Donders Centre for Neuroscience, Radboud University Nijmegen Medical Center, the Netherlands.
PMID:
34859515
DOI:
10.1111/add.15775
No abstract available
Keywords:
Addiction; QTc prolongation; adverse effects; ibogaine; opioid use disorder; safety.
Publication types
Letter
Comment
MeSH terms
Cardiotoxicity / drug therapy
Hallucinogens*
Humans
Ibogaine* / adverse effects
Opioid-Related Disorders* / drug therapy
Substances
Hallucinogens
Ibogaine